Infective Endocarditis: specific ABx Treatment & Management | USMLE Step 1, 2, 3 Review (Part 2)

Infective Endocarditis: Treatment & Management | High-Yield USMLE Step 1, Step 2 CK & Step 3 Review (Part 2) In this high-yield infective endocarditis review, we connect microbiology and antibiotic mechanisms with organism-specific treatment, clinical management, and important therapeutic decisions to help you prepare for USMLE Steps, and other board exams. Topics covered include: • Principles of infective endocarditis treatment and antibiotic selection • Empiric vs targeted antibiotic therapy • Methicillin-sensitive Staphylococcus aureus (MSSA) treatment with nafcillin, oxacillin, or cefazolin • Methicillin-resistant Staphylococcus aureus (MRSA) treatment with vancomycin or daptomycin • Why beta-lactams are preferred over vancomycin for susceptible MSSA infections • Enterococcus faecalis treatment with ampicillin plus ceftriaxone • Antibiotic synergy and mechanisms of action • Viridans streptococci and HACEK organism treatment • Native-valve vs prosthetic-valve infective endocarditis • Antibiotic susceptibility, minimum inhibitory concentration (MIC), and treatment individualization • Gentamicin-associated nephrotoxicity and important treatment considerations • High-yield USMLE clinical reasoning and management Please subscribe to USMLE Pump for more high-yield reviews! Part 1:    • Infective Endocarditis: Pathophysiology, C...   #usmle #USMLEStep1 #USMLEStep2CK #USMLEStep3 #InfectiveEndocarditis #Endocarditis #Antibiotics #MSSA #MRSA #EnterococcusFaecalis #StaphylococcusAureus #InfectiousDiseases #COMLEX #PANCE #NCLEX #Cardiology #USMLEPrep #MedicalEducation #InternalMedicine Disclaimer: This video is intended for educational and exam preparation purposes only. It is not a substitute for professional medical judgment, clinical guidelines, or individualized patient care. Medical information and recommendations may change as new evidence becomes available.